Journals / Cukurova Medical Journal / 2018 / Cilt: 43 - Sayı: 4

T helper, cytotoxic T, and natural killer T cell profiles and their association with clinical prognosis in children with sickle cell anemia

Orak hücreli anemisi olan çocuklarda T helper, T sitotoksik ve doğal öldürücü hücre profili ve klinik prognozla ilişkisi

Pages
1002–1007
Publication Date
2018-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NK T cell levels of the study group were higher than that of the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Our aim was to determine the effects of ischemic attacks on T cell profiles, immune functions and clinical prognosis in patients with sickle cell anemia.Materials and Methods: The study group consisted of 29 sickle cell anemia patients who were either in vaso-occlusive crisis or in steady state.
📊
Key Findings & Data:Flow-cytometry was used to assess the T-cell profiles.Results: The mean HbS in sickle cell anemia patients during vaso-occlusive crisis was 83±6.6%.
💡
Conclusion & Impact:NK T cell levels of the study group were higher than that of the control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:çocukluk çağı · doğal ödürücü T hücre · orak hücreli anemi

Abstract

Purpose: Our aim was to determine the effects of ischemic attacks on T cell profiles, immune functions and clinical prognosis in patients with sickle cell anemia.Materials and Methods: The study group consisted of 29 sickle cell anemia patients who were either in vaso-occlusive crisis or in steady state. Twenty-four age-matched healthy children served as the control group. All patients underwent complete blood cell count, hemoglobin electrophoresis, and blood chemistry analysis. Flow-cytometry was used to assess the T-cell profiles.Results: The mean HbS in sickle cell anemia patients during vaso-occlusive crisis was 83±6.6%. The CD3 levels of patients in vaso-occlusive crisis (62.31±7.79%) were lower compared to steady state (65.53±5.72 %) and healthy controls (69.09±9.18%). The NK T cell percentages of patients in vaso-occlusive crisis (13.07±7.67%) were higher than the control group (8.11±4.67%). Conclusion: Total T lymphocyte levels were found to be significantly lower in sickle cell anemia patients during vaso-occlusive crisis compared to healthy controls. NK T cell levels of the study group were higher than that of the control group.

Özet

Amaç: Orak hücreli anemide iskemik atakların T hücre profiline, immun fonksiyonlara ve klinik prognoza etkisinin araştırılması amaçlanmıştır.Gereç ve Yöntem: Bu çalışmaya 29 orak hücreli anemi hastası çocuklar çalışmaya dahil edildi. Çalışma grubu vazo-oklüzif kriz ve kriz dışı döneminde olan hastalardan oluşmaktaydı. Kontrol grubu olarak aynı yaş grubunda 24 sağlam çocuk alındı. Tüm çocuklardan tam kan sayımı, hemoglobin elektroforezi, kan biyokimyası çalışıldı. T hücre profilini belirlemek için akım sitometri yöntemi kullanıldı.Bulgular: Orak hücre anemili hastaların kriz dönemlerinde bakılan HbS ortalaması %83.8±6.6 bulundu. Orak hücre anemili hastaların kriz dönemlerinde bakılan CD3 değerleri (%62.31±7.79) aynı hastaların stabil dönemlerinde bakılan CD3 değerlerine (% 65,53±5,72) ve kontrol grubunda bakılan CD3 değerlerine (% 69,09±9,18) göre anlamlı olarak daha düşük bulundu. Orak hücre anemili hastaların kriz dönemlerinde bakılan doğal öldürücü T hücre değeri (%13.07±7.67) kontrol grubuna (%8.11±4.67) göre anlamlı olarak daha yüksek bulundu. Sonuç: Çalışma sonucunda kronik hemoliz ve doku hipoksisi ile seyreden orak hücre anemili hastalarda toplam T hücre sayısını gösteren CD3 değerleri vazo-oklüzif kriz döneminde kontrol grubuna göre daha düşük saptandı.. Doğal öldürücü T hücre seviyeleri çalışma grubunda kontrol grubuna göre yüksek bulundu.

🔖

Cite This Article

ATMIŞ, B., KILINÇ, Y., YILMAZ, M., ATMIŞ, A., KARAGÜN, B. Ş., ŞAŞMAZ, H. İ. (2018). T helper, cytotoxic T, and natural killer T cell profiles and their association with clinical prognosis in children with sickle cell anemia. Cukurova Medical Journal, Cilt: 43 - Sayı: 4, 1002–1007. https://ajindex.com/articles/56566

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 1910
  2. 517 2. Dover G, Platt O. Sickle cell disease. In: Nathan D, Orkin SH, Ginsburg D, Look AT (eds). Hematology of Infancy and Childhood. 6th ed, Philadelphia: WB Saunders Company, 2003: 790-841. 3. Wang WC, Lukens JN. Sickle cell anemia and other sickling syndromes. In: Richard Lee G, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds), Wintrobe’s Clinical Hematology Volume 1,10th Ed. Baltimore: Williams & Wilkins, 1999: 1346-1397. 4. Hernández P, Cruz C, Santos MN, Ballester JM. Immunologic dysfunction in sickle cell anaemia. Acta Haematol 1980
  3. 63(3):156-61. 5. Musa BO, Onyemelukwe GC, Hambolu JO, Mamman AI, Isa AH. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin Vaccine Immunol. 2010
  4. 17(4):602-8. 6. Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, Strieter RM, et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFNgamma and CXCR3 chemokines. Blood. 2009
  5. 114(3):667–676. 7. Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013
  6. 121(17):3329–3334. 8. Scheuplein F, Thariath A, Macdonald S, Truneh A, Mashal R, Schaub R. A humanized monoclonal antibody specific for invariant Natural Killer T (iNKT) cells for in vivo depletion. PLoS One. 2013
  7. 8(9):e76692. 9. Majerus EM, Ataga KI, Vichinsky E, Eaton CA, Mazanet R, Nathan DG, et al. NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial. Blood. 2014
  8. 124(21):2718. 10. Platt, O.S. Sickle cell anemia as an inflammatory disease. Journal of Clinical Investigation 2000:106, 337–338. 11. Makis AC, Hatzimichael EC, Bourantas KL.The role of cytokines in sickle cell disease.Ann Hematol. 2000 Aug
  9. 79(8):407-13. Review. 12. Kümi M, Kılınç Y, Etiz L. Hematological findings in the milder and severe forms of sickle cell disease. Çukurova Üniv Tıp Fak Der 1982
  10. 7(4):349-352. 13. Anyaegbu CC, Okpala IE, Akren'Ova YA, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA) Eur J Haematol. 1998 Apr
  11. 60(4):267-8. 14. Awogu AU. Leucocyte counts in children with sickle ce